|
|
|
|
| Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Henning Stennicke, Chief Scientific Officer at Spur Therapeutics | GBA1 mutations, which cause Gaucher disease and are the most common genetic risk factor for Parkinson's disease. | |
|
|
|
|
|
| Demystifying CRISPR gRNA Chemical Modifications | Article | By Rebecca Roberts, Ph.D., Kevin Holden, Ph.D., and Adrianna Zepeda, Synthego Corporation | Chemical modifications on CRISPR gRNAs enhance stability, editing efficiency, and reduce immune responses, enabling in vivo applications and clinical success. |
|
|
| Automated Setup And Compensation On BD FACSLyric Flow Cytometer | Application Note | By Casey J. Fox, Mamatha Bharadwaj, Dina Huckaby, et al., BD Biosciences | Examine the usability and performance capabilities of a system that provides a streamlined flow cytometry workflow, from instrument initialization to data acquisition and analysis. |
|
|
|
|
| Development And Optimization Of LNP Formulations | Application Note | KNAUER | The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs. |
|
|
| Accelerate Antibody Development And Production | e-book | MaxCyte, Inc. | MaxCyte's electroporation platform accelerates therapeutic antibody development with scalable, high-efficiency transfection, enabling rapid transient protein expression, and IND-enabling studies in weeks. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
Connect With Cell & Gene: |
|
|
|